We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Shenzhen New Industries Biomedical Engineering Co., Ltd. (SNIBE)

Shenzhen New Industries Biomedical Engineering Co., Ltd. (SNIBE) is a biotechnology company specializing in clinical ... read more Featured Products: More products

Download Mobile App





Snibe Demonstrates Cutting-Edge Diagnostic Solutions

By LabMedica International staff writers
Posted on 04 Feb 2025
Print article
Image: The space-saving DxC 500i clinical analyzer delivers high-quality chemistry and immunoassay results (Photo courtesy of Snibe)
Image: The space-saving DxC 500i clinical analyzer delivers high-quality chemistry and immunoassay results (Photo courtesy of Snibe)

Snibe (Shenzhen, China) is offering live demonstrations of its cutting-edge diagnostic solutions at Medlab Middle East 2025.

Snibe is highlighting the MAGLUMI X Series CLIA analyzers which is designed to meet the different demands of clinical diagnostics, offering advanced automation, precision, and flexibility. With features like high throughput and seamless integration, it makes a lab's workflow smoother and more efficient. The MAGLUMI X series includes the compact and efficient MAGLUMI X3, designed to maintain high performance within a small footprint. The MAGLUMI X8 features an ultra-high-speed module tailored for high-throughput needs, while the MAGLUMI X6 bridges the gap between the X3 and X8. Each model incorporates Snibe’s revolutionary X-Tech, delivering an exceptional performance experience.

Additionally, Snibe is highlighting the SATLARS-T8, a versatile total laboratory automation solution offering extraordinary efficiency, flexibility, compatibility, and intelligence. It is compatible with Snibe’s extremely high-throughput and multi-discipline laboratory solutions, to meet most clinical testing requirements. Also featured at the event is the powerful and highly flexible SATLARS-TCA Total Laboratory Automation system. Compatible with high-throughput analyzers in multiple disciplines, SATLARS-TCA can minimize the need for manual intervention and greatly improve the testing efficiency of labs. Visitors to the Snibe booth can also experience the Biolumi CX8 integrated system that combines two powerful systems--- Biossays C8 and MAGLUMI X8, to achieve simultaneous biochemical and immunological testing. Moreover, it not only has an ultra-high throughput in a minimal footprint, but can also be customized according to your needs, supporting up to 4 instruments connected, and covering the demands of different laboratories.

 

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory QC Panel
Assayed Respiratory Control Panel

Print article

Channels

Clinical Chemistry

view channel
Image: The research team has developed the uCR-Chip device to enhance kidney function testing (Photo courtesy of University of Manitoba)

Low-Cost Portable Screening Test to Transform Kidney Disease Detection

Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.